Jeffrey S. Montgomery

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

Dipen J. Parekh, Isildinha M. Reis, Erik P. Castle et al. · The Lancet · 2018 · 763 citations

Medicine, Surgery, Urology +16

Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2020 · 628 citations · Full text

Medicine, Oncology, Urology +16

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 442 citations · Full text

Medicine, Oncology, Urology +13

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022

Thomas W. Flaig, Philippe E. Spiess, Michael Abern et al. · Journal of the National Comprehensive Cancer Network · 2022 · 302 citations · Full text

Medicine, Oncology, Urology +17

Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Homayoun Zargar, Patrick Espiritu, Adrian Fairey et al. · European Urology · 2014 · 297 citations

Medicine, Oncology, Urology +13